Publications by authors named "T Miyabayashi"
Article Synopsis
- This study explores the use of a post-tetanic MEP augmentation technique to improve baseline recordings during craniotomies while minimizing neuromuscular blockade (NMB).
- It involved 26 patients, maintaining a partial NMB level to achieve successful MEPs through tetanic stimulation of the median nerve before transcranial stimulation.
- The technique increased the success rate of recordings to 100% and improved response amplitudes without causing any unexpected movements, suggesting it could be an effective approach for safer craniotomy procedures.
Juvenile myasthenia gravis (JMG) exhibits a more favorable response to glucocorticoids and has a better prognosis than adult myasthenia gravis. However, no established treatment exists for refractory JMG. Although thymectomy has been performed in several patients with refractory systemic JMG, there are few detailed clinical descriptions of patients who underwent thymectomy.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the effectiveness and safety of amrubicin (AMR) therapy in patients with recurrent small cell lung cancer (SCLC) following treatment with immune checkpoint inhibitors (ICIs) and chemotherapy.
- A total of 30 patients were analyzed, with median progression-free survival of 3.8 months and overall survival of 10 months; results were similar regardless of cancer sensitivity to prior treatments.
- The most frequent serious side effect was severe neutropenia, affecting 73% of patients, leading to two cases of treatment discontinuation due to adverse effects.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired demyelinating disease of the peripheral nervous system with unknown etiology. Alopecia universalis, an advanced form of alopecia areata (AA), is a condition characterized by complete hair loss. Here we report the first case of childhood CIDP associated with AA who was successfully treated with a combination of intravenous immunoglobulin (IVIg) and corticosteroids.
View Article and Find Full Text PDFIntroduction: Malignant tumors are the major cause of death in hemodialysis patients. Management of these patients remains challenging as there is no evidence that chemotherapy is beneficial, and a lack of information about actual clinical practice.
Methods: This multicenter retrospective study included hemodialysis patients who were diagnosed with lung cancer from January 2002 to June 2018.